Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06537167
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-31
Brief Title:
Transcutaneous Electrical Acupoint Stimulation on Blood Pressure
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Antihypertensive Effects of Transcutaneous Electrical Acupoint Stimulation in Patients With High-normal Blood Pressure and Grade 1 Hypertension
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will be conducted in patients with high-normal blood pressure and grade 1 hypertension and will be divided into two phases
In Phase One a small group of patients will undergo transcutaneous electrical acupoint stimulation treatment for three consecutive days Blood pressure changes will be observed before and after each stimulation session as well as 1 hour 3 hours and 5 hours after stimulation during the night of the treatment day and the next morning
Phase Two will be a single-center single-blind parallel randomized controlled trial After screening patients will be randomly assigned to either the stimulation experimental group or the sham stimulation control group For three consecutive days both groups will receive their respective interventions at the same time each day and their blood pressure changes will be recorded
In Phase One a small group of patients will undergo transcutaneous electrical acupoint stimulation treatment for three consecutive days Blood pressure changes will be observed before and after each stimulation session as well as 1 hour 3 hours and 5 hours after stimulation during the night of the treatment day and the next morning
Phase Two will be a single-center single-blind parallel randomized controlled trial After screening patients will be randomly assigned to either the stimulation experimental group or the sham stimulation control group For three consecutive days both groups will receive their respective interventions at the same time each day and their blood pressure changes will be recorded
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None